Epidemiological Study on Case Definition of Methicillin-Resistant Staphylococcus aureus Enteritis
Related Experiment Video
Updated: Jun 7, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Yusuke Yagi1,2, Akito Doke1,3, Saya Iwame1,3
1Department of Infection Prevention and Control, Kochi Medical School Hospital, Nankoku, Kochi, Japan.
Background:
Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is a condition in which MRSA grows abnormally in the intestine after administration of antimicrobial agents, resulting in enteritis. Patients with MRSA detected in stool culture tests are often diagnosed with MSRA enteritis. However, uncertainty remains in the diagnostic criteria; therefore, we conducted epidemiological studies to define these cases.
Patients And Methods:
Patients who tested positive for MRSA by stool culture using selective media 48 h after admission to Kochi Medical School Hospital between April 1, 2012, and December 31, 2022, and did not meet the exclusion criteria were included. We defined MRSA enteritis (Group A) as cases that were responsive to treatment with vancomycin hydrochloride powder, had a Bristol Stool Scale of ≥ 5, and a stool frequency of at least three times per day; all others were MRSA carriers (Group B). Multivariate analysis was performed to risk factors associated with MRSA enteritis.
Results:
Groups A and B included 18 (25.4%) and 53 (74.6%) patients, respectively. Multivariate logistic regression analysis showed that a white blood cell count of > 10000/µL (odds ratio [OR], 5.50; 95% confidence interval [CI], 1.12-26.9), MRSA count of ≥ 2+ in stool cultures (OR, 8.91; 95% CI, 1.79-44.3), and meropenem administration within 1 month of stool specimen submission (OR, 7.47; 95% CI, 1.66-33.6) were risk factors of MRSA enteritis.
Conclusion:
The case definitions reviewed for MRSA enteritis may be useful as diagnostic criteria.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) enteritis diagnosis can be improved by identifying key risk factors. Elevated white blood cell counts, high MRSA stool culture counts, and recent meropenem use are significant indicators.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) enteritis arises from abnormal intestinal MRSA growth post-antibiotic use.
- Current diagnostic criteria for MRSA enteritis lack clarity, necessitating epidemiological studies.
- Distinguishing MRSA enteritis from asymptomatic MRSA carriage is clinically important.
Purpose of the Study:
- To define diagnostic criteria for MRSA enteritis through epidemiological investigation.
- To identify risk factors associated with the development of MRSA enteritis.
Main Methods:
- A cohort of patients with positive MRSA stool cultures was analyzed.
- MRSA enteritis was defined by response to vancomycin, severe diarrhea (Bristol Stool Scale ≥ 5), and high stool frequency (≥ 3/day).
- Multivariate logistic regression identified risk factors for MRSA enteritis.
Main Results:
- 18 patients (25.4%) were classified with MRSA enteritis (Group A) and 53 (74.6%) as MRSA carriers (Group B).
- Risk factors for MRSA enteritis included elevated white blood cell count (> 10000/µL), high MRSA stool culture counts (≥ 2+), and recent meropenem administration (within 1 month).
- Odds ratios for these factors ranged from 5.50 to 8.91.
Conclusions:
- The proposed case definitions for MRSA enteritis may serve as valuable diagnostic criteria.
- Identifying these risk factors can aid in the accurate diagnosis of MRSA enteritis.
More Related Videos
Related Concept Videos
Investigation of Disease Outbreaks
Staphylococcal Skin Infections
Bacterial Gastroenteritis
Mechanism of Antibiotic Resistance in MRSA
Amebiasis
Clinical Significance of Antibiotic Resistance

